Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 607-997-7 | CAS number: 26776-30-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Identification
- Display Name:
- Copolymer of hexahydro-2H-azepin-2-one and 1,6-diisocyanatohexane
- EC Number:
- 607-997-7
- CAS Number:
- 26776-30-7
- Molecular formula:
- Exact identification is not feasible
- IUPAC Name:
- Copolymer of hexahydro-2H-azepin-2-one and 1,6-diisocyanatohexane
Type of Substance
- Composition:
- UVCB
- Origin:
- organic
Substance Identifiers open all close all
Compositions
Boundary Composition(s) open all close all
- State Form:
- other: sticky and pasty solid
Constituent 1
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C42 H69 N9 O9
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 2
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C64 H104 N14 O14
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 3
- Reference substance name:
- hexane-1,6-diisocyanate, oligomerization product ((isocyanurate type), n=7, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- C86 H139 N19 O19
- IUPAC Name:
- hexane-1,6-diisocyanate, oligomerization product ((isocyanurate type), n=7, blocked with hexahydro-2H-azepin-2-one
Constituent 4
- Reference substance name:
- hexane-1,6-diisocyanate, oligomerization product (isocyanurate type), n>=9, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- >= C108 H174 N24 O24
- IUPAC Name:
- hexane-1,6-diisocyanate, oligomerization product (isocyanurate type), n>=9, blocked with hexahydro-2H-azepin-2-one
Constituent 5
- Reference substance name:
- N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide)
- EC Number:
- 227-563-7
- EC Name:
- N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide)
- CAS Number:
- 5888-87-9
- Molecular formula:
- C20H34N4O4
- IUPAC Name:
- N,N'-hexane-1,6-diylbis(2-oxoazepane-1-carboxamide)
Constituent 6
- Reference substance name:
- ε-caprolactam
- EC Number:
- 203-313-2
- EC Name:
- ε-caprolactam
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- azepan-2-one
Legal Entity Composition(s) open all close all
- State Form:
- other: sticky and pasty solid
Constituent 1
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C42 H69 N9 O9
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 2
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C64 H104 N14 O14
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 3
- Reference substance name:
- hexane-1,6-diisocyanate, oligomerization product ((isocyanurate type), n=7, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- C86 H139 N19 O19
- IUPAC Name:
- hexane-1,6-diisocyanate, oligomerization product ((isocyanurate type), n=7, blocked with hexahydro-2H-azepin-2-one
Constituent 4
- Reference substance name:
- hexane-1,6-diisocyanate, oligomerization product (isocyanurate type), n>=9, blocked with hexahydro-2H-azepin-2-one
- Molecular formula:
- >= C108 H174 N24 O24
- IUPAC Name:
- hexane-1,6-diisocyanate, oligomerization product (isocyanurate type), n>=9, blocked with hexahydro-2H-azepin-2-one
Constituent 5
- Reference substance name:
- N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide)
- EC Number:
- 227-563-7
- EC Name:
- N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide)
- CAS Number:
- 5888-87-9
- Molecular formula:
- C20H34N4O4
- IUPAC Name:
- N,N'-hexane-1,6-diylbis(2-oxoazepane-1-carboxamide)
Constituent 6
- Reference substance name:
- ε-caprolactam
- EC Number:
- 203-313-2
- EC Name:
- ε-caprolactam
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- azepan-2-one
- State Form:
- other: Solid paste
Constituent 1
- Reference substance name:
- 1,3,5-Tris{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinane-2,4,6-trione
- Molecular formula:
- C42H69N9O9
- IUPAC Name:
- 1,3,5-Tris{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinane-2,4,6-trione
Constituent 2
- Reference substance name:
- 3,5-Bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
- Molecular formula:
- C64H104N14O14
- IUPAC Name:
- 3,5-Bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
Constituent 3
- Reference substance name:
- 5-{6-[(2-Oxo-1-azepanyl)carbonylamino]hexyl}-1-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-3-[6-(2,4,6-trioxo-5-{7-[(2-oxo-1-azepanyl)carbonylamino]heptyl}-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
- Molecular formula:
- C87H141N19O19
- IUPAC Name:
- 5-{6-[(2-Oxo-1-azepanyl)carbonylamino]hexyl}-1-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-3-[6-(2,4,6-trioxo-5-{7-[(2-oxo-1-azepanyl)carbonylamino]heptyl}-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
Constituent 4
- Reference substance name:
- 1,3-Bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3-diazetidine-2,4-dione
- Molecular formula:
- C28H46N6O6
- IUPAC Name:
- 1,3-Bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3-diazetidine-2,4-dione
Constituent 5
- Reference substance name:
- 1,3-Bis[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-5-[6-(2,4,6-trioxo-5-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-3-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
- Molecular formula:
- C130H209N29O29
- IUPAC Name:
- 1,3-Bis[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-5-[6-(2,4,6-trioxo-5-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-3-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
Constituent 6
- Reference substance name:
- The substance is a UVCB
- Molecular formula:
- The substance is a UVCB
- IUPAC Name:
- The substance is a UVCB
Constituent 7
- Reference substance name:
- 3-[6-(2,4-Dioxo-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3-diazetidin-1-yl)hexyl]-5-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
- Molecular formula:
- C72H164N16O16
- IUPAC Name:
- 3-[6-(2,4-Dioxo-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3-diazetidin-1-yl)hexyl]-5-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1-[6-(2,4,6-trioxo-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
Constituent 8
- Reference substance name:
- 5-{6-[(2-Oxo-1-azepanyl)carbonylamino]hexyl}-3-[6-(2,4,6-trioxo-5-{7-[(2-oxo-1-azepanyl)carbonylamino]heptyl}-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1-[6-(2,4,6-trioxo-5-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-3-[5-(2,4,6-trioxo-5-{7-[(2-oxo-1-azepanyl)carbonylamino]heptyl}-3-{5-[(2-oxo-1-azepanyl)carbonylamino]pentyl}-1,3,5-triazinan-1-yl)pentyl]-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
- Molecular formula:
- C108H174N24O24
- IUPAC Name:
- 5-{6-[(2-Oxo-1-azepanyl)carbonylamino]hexyl}-3-[6-(2,4,6-trioxo-5-{7-[(2-oxo-1-azepanyl)carbonylamino]heptyl}-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinan-1-yl)hexyl]-1-[6-(2,4,6-trioxo-5-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-3-[5-(2,4,6-trioxo-5-{7-[(2-oxo-1-azepanyl)carbonylamino]heptyl}-3-{5-[(2-oxo-1-azepanyl)carbonylamino]pentyl}-1,3,5-triazinan-1-yl)pentyl]-1,3,5-triazinan-1-yl)hexyl]-1,3,5-triazinane-2,4,6-trione
Constituent 9
- Reference substance name:
- 1-[6-(2,4-Dioxo-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3-diazetidin-1-yl)hexyl]-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinane-2,4,6-trione
- Molecular formula:
- C50H81N11O11
- IUPAC Name:
- 1-[6-(2,4-Dioxo-3-{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3-diazetidin-1-yl)hexyl]-3,5-bis{6-[(2-oxo-1-azepanyl)carbonylamino]hexyl}-1,3,5-triazinane-2,4,6-trione
Constituent 10
- Reference substance name:
- ε-caprolactam
- EC Number:
- 203-313-2
- EC Name:
- ε-caprolactam
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- azepan-2-one
- State Form:
- liquid
Constituent 1
- Reference substance name:
- (2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide)
- CAS Number:
- 1044266-39-8
- Molecular formula:
- C42H69N9O9
- IUPAC Name:
- (2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide)
Constituent 2
- Reference substance name:
- (2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide)
- Molecular formula:
- C64H104N14O14
- IUPAC Name:
- (2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide)
Constituent 3
- Reference substance name:
- (Hexane-1,6-diisocyanate, oligomerization product ((isocyanurate type), n=7,blocked with hexahydro-2Hazepin-2-one)
- Molecular formula:
- C86H139N19O19
- IUPAC Name:
- (Hexane-1,6-diisocyanate, oligomerization product ((isocyanurate type), n=7,blocked with hexahydro-2Hazepin-2-one)
Constituent 4
- Reference substance name:
- (hexane-1,6-diisocyanate,oligomerization product (isocyanurate type), n>=9, blocked with hexahydro-2Hazepin-2-one)
- IUPAC Name:
- (hexane-1,6-diisocyanate,oligomerization product (isocyanurate type), n>=9, blocked with hexahydro-2Hazepin-2-one)
Constituent 5
- Reference substance name:
- N,N'-hexane-1,6-diylbis(2-oxoazepane-1-carboxamide)
- CAS Number:
- 5888-87-9
- Molecular formula:
- C20H34N4O4
- IUPAC Name:
- N,N'-hexane-1,6-diylbis(2-oxoazepane-1-carboxamide)
Constituent 6
- Reference substance name:
- Hexahydro-2H-azepin-2-one
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- Hexahydro-2H-azepin-2-one
Constituent 1
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- CAS Number:
- 1044266-39-8
- Molecular formula:
- C42H69N9O9
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 2
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C64H104N14O14
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 3
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C86H139N19O19
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 4
- Reference substance name:
- not applicable
- Molecular formula:
- >=C108H174N24O24
- IUPAC Name:
- not applicable
Constituent 5
- Reference substance name:
- ε-caprolactam
- EC Number:
- 203-313-2
- EC Name:
- ε-caprolactam
- CAS Number:
- 105-60-2
- Molecular formula:
- C6H11NO
- IUPAC Name:
- azepan-2-one
Constituent 6
- Reference substance name:
- Hexamethylene diisocyanate
- EC Number:
- 212-485-8
- EC Name:
- Hexamethylene diisocyanate
- CAS Number:
- 822-06-0
- Molecular formula:
- C8H12N2O2
- IUPAC Name:
- 1,6-diisocyanatohexane
- State Form:
- other: resinous
Constituent 1
- Reference substance name:
- N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide)
- EC Number:
- 227-563-7
- EC Name:
- N,N'-hexane-1,6-diylbis(hexahydro-2-oxo-1H-azepine-1-carboxamide)
- CAS Number:
- 5888-87-9
- Molecular formula:
- C20H34N4O4
- IUPAC Name:
- N,N'-hexane-1,6-diylbis(2-oxoazepane-1-carboxamide)
Constituent 2
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C42H69N9O9
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 3
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C64H104N14O14
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 4
- Reference substance name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
- Molecular formula:
- C86H139N19O19
- IUPAC Name:
- 2-oxo-N-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3-(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-5-{6-[2,4,6-trioxo-3,5-bis(6-{[(2-oxoazepan-1-yl)carbonyl]amino}hexyl)-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}-1,3,5-triazinan-1-yl]hexyl}azepane-1-carboxamide
Constituent 5
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_2
- Molecular formula:
- C29H50N7O6
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_2
Constituent 6
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_3
- Molecular formula:
- C29H51N6O7
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_3
Constituent 7
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_4
- Molecular formula:
- C28H47N6O6
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_4
Constituent 8
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_5
- Molecular formula:
- C41H72N9O8
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_5
Constituent 9
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_6
- Molecular formula:
- C49H84N11O10
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_6
Constituent 10
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_7
- Molecular formula:
- C44H82N6O8Na
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_7
Constituent 11
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_9
- Molecular formula:
- C42H70N9O9
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_9
Constituent 12
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_10
- Molecular formula:
- C71H119N16O15
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_10
Constituent 13
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_12
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_12
Constituent 14
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_13
- Molecular formula:
- C36H64N6O7
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_13
Constituent 15
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_14
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_14
Constituent 16
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_15
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_15
Constituent 17
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_16
- Molecular formula:
- C64H110N12O14
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_16
Constituent 18
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_18
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_18
Constituent 19
- Reference substance name:
- HDI-Oligomers-CL-Blocked_Constituent_19
- Molecular formula:
- C58H99N11O12
- IUPAC Name:
- HDI-Oligomers-CL-Blocked_Constituent_19
Composition(s) generated upon use
Other types of composition(s)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.